Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
1-beta-D-ribofuranosyl-1H-benzotriazole
1-beta-D-ribofuranosyl-4,5,6,7-tetrabromo-1H-benzotriazole
1-beta-D-ribofuranosyl-4,5,6,7-tetramethyl-1H-benzotriazole
1-beta-D-ribofuranosyl-4,7-dibromo-1H-benzotriazole
1-chloroethyl-4,5,6,7-tetrabromo-1H-benzotriazole
1-ethyl-4,5,6,7-tetrabromo-1H-benzotriazole
1-hydroxyethyl-4,5,6,7-tetrabromo-1H-benzotriazole
1-methyl-4,5,6,7-tetrabromo-1H-benzotriazole
1-propyl-4,5,6,7-tetrabromo-1H-benzotriazole
2',3'-didehydro-thymidine triphosphate
-
competitive to ATP
2',3'-dideoxy-5-fluorocytidine triphosphate
-
competitive to ATP
2-chloroethyl-4,5,6,7-tetrabromo-1H-benzotriazole
2-ethyl-4,5,6,7-tetrabromo-1H-benzotriazole
2-hydroxyethyl-4,5,6,7-tetrabromo-1H-benzotriazole
2-methyl-4,5,6,7-tetrabromo-1H-benzotriazole
2-propyl-4,5,6,7-tetrabromo-1H-benzotriazole
3'-azido-2',3'-dideoxythymidine triphosphate
-
competitive to ATP
4,5,6,7-tetrabromo-1H-benzotriazole
4,5-dihydro-8H-6-(N-decyl)amino-1-(beta-D-ribofuranosyl)imidazo[4,5-e][1,3]diazepine-4,8-dione
-
IC50: 30-100 mg/l
4,5-dihydro-8H-6-(N-dodecyl)amino-1-(beta-D-ribofuranosyl)imidazo[4,5-e][1,3]diazepine-4,8-dione
-
IC50: 1-3 mg/l
4,5-dihydro-8H-6-(N-dodecylamino)-1-(2'-deoxy-alpha-D-erythropentofuranosyl)imidazo[4,5-e][1,3]diazepine-4,8-dione
-
IC50: 3-10 mg/l
4,5-dihydro-8H-6-(N-dodecylamino)-1-(2'-deoxy-beta-D-erythropentofuranosyl)imidazo[4,5-e][1,3]diazepine-4,8-dione
-
IC50: 3-10 mg/l
4,5-dihydro-8H-6-(N-hexadecyl)amino-1-(beta-D-ribofuranosyl)imidazo[4,5-e][1,3]diazepine-4,8-dione
-
IC50: 250 mg/l
4,5-dihydro-8H-6-(N-octadecyl)amino-1-(beta-D-ribofuranosyl)imidazo[4,5-e][1,3]diazepine-4,8-dione
-
IC50: 5.0 mg/l
4,5-dihydro-8H-6-(N-tetradecyl)amino-1-(beta-D-ribofuranosyl)imidazo[4,5-e][1,3]diazepine-4,8-dione
-
IC50: 3-10 mg/l
5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzotriazole
5-fluoro-2-selenocytosine
-
IC50: 0.075 mM for NTPase reaction, no influence to helicase activity up to a concentration of 0.5 mM
beta,gamma-methylene-ATP
-
-
Ca2+
-
at high concentrations
CaCl2
in presence of Mn2+, 10 mM MgCl2 inhibits 20%
choline
-
at concentration above 20 mM
Cs+
-
at concentration above 20 mM
dATP
-
competitive to ATP
dCTP
-
competitive to ATP
ddCTP
-
competitive to ATP
ddTTP
-
competitive to ATP
dGTP
-
competitive to ATP
dTTP
-
competitive to ATP
formononetin 7-O-glucoside
-
-
guanidine hydrochloride
-
-
HOCl
-
inhibits the muclear NTPase, taurine acts as antagonist and reduces the hypochlorous acid toxicity
L-dATP
-
competitive to ATP
L-dCTP
-
competitive to ATP
L-ddCTP
-
competitive to ATP
L-dTTP
-
competitive to ATP
MgCl2
in presence of Mn2+, 10 mM MgCl2 inhibits 10%
NaCl
100 mM, inhibits ATP hydrolysis by 30%
O6-benzyl-N7-chloroethylguanine
-
weak inhibition of NTPase activity, enhances helicase activity
O6-benzylguanine
-
weak inhibitor of ATPase and helicase activity
oligo(dA)25
-
above 0.5 mM, inhibits unwinding reaction
-
p-hydroxymercuribenzoate
-
-
polyA
inhibits to a lesser extent than polyC and polyU
polyC
1 mg/l, 70% inhibition
polyG
inhibits to a lesser extent than polyC and polyU
polyU
1 mg/l, 70% inhibition
propionate
-
39% relative activity at a concentration of 0.5 mM, 63% relative activity at a concentration of 0.05 mM
Rb+
-
at concentration above 20 mM
ribavirin-TP
-
at ATP concentration equal to Km, IC50 of NTPase reaction is 0.4 mM, classical competitive inhibitor with regard to ATP. At ATP and DNA duplex concentrations corresponding to their KM-values an IC50 of 0.12 mM is measured. Inhibition reaches a maximum of 30% of the control at 0.45 mM and is not competitive with regard to ATP
RNA
homopolymeric RNA inhibits under otherwise optimal conditions
1-beta-D-ribofuranosyl-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-4,5,6,7-tetramethyl-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-4,5,6,7-tetramethyl-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-4,5,6,7-tetramethyl-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-4,5,6,7-tetramethyl-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-4,7-dibromo-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-4,7-dibromo-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-4,7-dibromo-1H-benzotriazole
-
-
1-beta-D-ribofuranosyl-4,7-dibromo-1H-benzotriazole
-
-
1-chloroethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-chloroethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-chloroethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-chloroethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-ethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-ethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-ethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-ethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-hydroxyethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-hydroxyethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-hydroxyethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-hydroxyethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-methyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-methyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-methyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-methyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-propyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-propyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-propyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
1-propyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-chloroethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-chloroethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-chloroethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-chloroethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-ethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-ethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-ethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-ethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-hydroxyethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-hydroxyethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-hydroxyethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-hydroxyethyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-methyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-methyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-methyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-methyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-propyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-propyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-propyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
2-propyl-4,5,6,7-tetrabromo-1H-benzotriazole
-
-
4,5,6,7-tetrabromo-1H-benzotriazole
-
-
4,5,6,7-tetrabromo-1H-benzotriazole
-
-
4,5,6,7-tetrabromo-1H-benzotriazole
-
-
4,5,6,7-tetrabromo-1H-benzotriazole
-
-
5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzotriazole
-
-
5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzotriazole
-
-
5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzotriazole
-
-
5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzotriazole
-
-
EDTA
-
-
K+
-
at concentration above 20 mM
Na+
-
at concentration above 20 mM
rNTP
-
ribotrinucleotides inhibit the activity with gammaATP
rNTP
-
ribotrinucleotides inhibit the activity with gammaATP
additional information
-
inhibitor cytotoxicity study, overview
-
additional information
-
inhibitor cytotoxicity study, overview
-
additional information
-
inhibitor cytotoxicity study, overview
-
additional information
-
a polyclonal immune serum produced against the anti-r-pot B domain, also produced against synthetic peptides LbB1LJ and LbB2LJ derived from this domain, recognizes specifically the B domain of NTPDase 1. The polyclonal antibodies have effective antileishmanial effect, reducing significantly in vitro promastigotes growth by 21-25%. An antiproliferative effect is also demonstrated by immune sera produced against recombinant r-pot B domain, and two other synthetic peptides, potB1LJ and potB2LJ
-
additional information
-
the ATPase domain of Cdc6-3, although having lost much of its DNA-binding activity from the origin, inhibits both Cdc6-1 and Cdc6-2
-
additional information
transcript release is inhibited when the non-template strand of DNA is removed from the transcription bubble
-
additional information
-
transcript release is inhibited when the non-template strand of DNA is removed from the transcription bubble
-
additional information
-
inhibitor cytotoxicity study, overview
-